*** Professional BBing x Avanzati ***

[menphisdaemon]

Beh ho ripensato molto a quello che mi hai detto...le tre condizioni che ci si possono presentare più facilmente, i segnali di cui mi hai parlato...sicuramente mi è servito per capire ulteriori dettagli. Non nego che il potassio non lo avrei usato con il senno del poi...e forse anche i liquidi andavano gestiti meglio, ma...come dice il mio amicone Fede...tutto fa esperienza!!! Aggiungo io che provarle di persona è un altro mondo...una delle cose di cui posso andare fiero è di aver sperimentato non dico tutti ma quasi i sys di allenamento e dietetici.

Cmq non mi hai più risp...non so se perchè ti sei arrabbiato o se perchè pensi che sia uno zuccone e che non ti ascolti. Ho visto che hai letto il diario quindi già sai qual'è stata la scelta...come ha detto Fede...mi è sembrato sensato e quindi sono andato per la settimana in low. Approccio WO ho seguito il tuo consiglio...sensazione, volume, cardio.

Per la ripresa 250/100 con gestione volume e cardio...salgo e mi tengo in condizione...approccio parmense...nessuna tirata dritta stavolta.

[dr.j]

No Marco, invece ci sta la linea che hai preso....mi son scordato di risponderti.....sorry......che ti ho detto ieri? dopo questa ricaricata massiccia(che cmq non mi piace "solitamente" in certi contesti precontest) e mista, un approccio low carbs.....+cardio.......arriverai ora ancora meglio questo fine settimana. Credi ad un cocones......

[Mezzo86]

Caro coach ti scrivo...

YouTube - Kai Greene - "The Effort of using your mind"

[dr.j]

Altra cosa da tenere in mente Marco, relativa ai discorsi fatti è che devi veramente individuare un buon sistema di allenamento, ben ciclizzato, con esercizi target e supportarti con un'alimentazione veramente "solida" nel senso lato della cosa sono ripetitivo? un po' è che son abituato a certi "canoni" e l'altra parte.....sono un arteriosclerotico! Detto questo.....Fede mi ha appena detto che secondo lui dovresti passare più tempo in sua/nostra compagnia!

[dr.j]

Caro coach ti scrivo...

YouTube - Kai Greene - "The Effort of using your mind"

Bellissimo video Fede
Cerca di allenarti qualche volta con Marco....tra spilungoni....

[DORIAN]

da settembre doc verro' a trovarti spesso la domenica per dei w.o. assieme...

[menphisdaemon]

Ottimo. Mi mancava l'approvazione come l'acqua santa.

Come ti accennavo ieri...dallo spunto di pippo mio ho approfondito...diciamo che pippo ed io facciamo danni quando ci fissiamo su certe cosette.. vero Vale??


Toxicity studies of Blockal, a dietary supplement containing Phase 2 Starch Neutralizer (Phase 2), a standardized extract of the common white kidney bean (Phaseolus vulgaris).
Chokshi D.

Pharmachem Laboratories, Inc., Kearny, New Jersey 07032, USA.
Abstract
The number of available dietary supplements containing "starch blockers" intended for weight loss has risen dramatically in recent years. These supplements are believed to reduce carbohydrate-derived calories by interfering with alpha-amylase, the digestive enzyme responsible for conversion of complex carbohydrates to simple absorbable sugars. The present paper reports the findings of single- and multiple-dose (4-week) oral toxicity studies in rats of the marketed dietary supplement Blockal. Blockal contains as its main ingredient Phase 2 Starch Neutralizer (Phase 2 or Phaseolamin 2250), a standardized extract derived from the common white kidney bean (Phaseolus vulgaris) that has been shown to have alpha-amylase-inhibiting activity. The Blockal acute oral LD50 exceeded the highest dose tested (3 g/kg body weight [bw]), which provided a single dose of 1668 mg/kg bw of Phase 2 white kidney bean extract. The no-observed-effect level (NOEL) seen in the 4-week study was equivalent to the highest Blockal dose tested (2 g/kg bw/day), which provided 1112 mg/kg/day of Phase 2 white kidney bean extract. The results of these studies support and are consistent with the safety of the marketed dietary supplement Blockal, and indirectly, the safety of its main ingredient, Phase 2 Starch Neutralizer (Phase 2 or Phaseolamin 2250), a standardized extract derived from the common white kidney bean.

Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans.
Layer P, Zinsmeister AR, DiMagno EP.

Abstract
We used an amylase inhibitor preparation that markedly improves postprandial carbohydrate tolerance in humans to investigate the effects of decreased intraluminal amylase activity on digestion of starch and postprandial gastrointestinal and hormonal responses. Four fasting volunteers were intubated with an oroileal tube to obtain duodenal, jejunal, and terminal ileal samples. After intubation, subjects ingested 50 g of rice starch given with placebo; on the second day, starch was given with the amylase inhibitor. Compared with placebo, the amylase inhibitor significantly (p less than 0.05) reduced duodenal, jejunal, and ileal intraluminal amylase activity by more than 95% for 1-2 h; increased postprandial delivery of total carbohydrate (glucose polymers in particular) to the distal small bowel; increased breath hydrogen concentrations; decreased intestinal water absorption and increased distal intestinal volume delivery to the distal bowel; shortened duodenoileal transit time but doubled postprandial gastric emptying time; reduced the early postprandial plasma glucose rise by 85% and eliminated the late postprandial glucose fall to below fasting levels; and abolished postprandial plasma concentrations of insulin, C-peptide, and gastric inhibitory polypeptide. Postprandial trypsin output was not influenced. We conclude that more than 95% inhibition of amylase reduces dietary starch digestion within the small intestine and uptake of dietary starch from the small intestine, markedly decreases postprandial release of insulin and gastric inhibitory polypeptide, and may alter postprandial upper gastrointestinal motor function.

A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man
GL Carlson, BU Li, P Bass, and WA Olsen

A commercial alpha-amylase inhibitor with potent inhibitory activity in vitro was used in a randomized double-blind, cross-over clinical trial in six nonobese, healthy adult males. In these subjects, this inhibitor had no effect on the response of blood glucose, insulin, or breath hydrogen to a standardized starch meal. It is concluded that this formulation has no effect on starch digestion in humans.

Use of Phaseolamin (white kidney bean extract) Starch Neutralizer� brand bean extract for weight loss: a randomized controlled trial

Background: The Phaseolamin (white kidney bean extract) starch neutralizer brand bean extract product is a water-extract of a common white bean (Phaseolus Vulgaris), which has been shown in vitro to inhibit the digestive enzyme alpha-amylase. Alpha-Amylase is secreted in saliva and by the pancreas and is responsible for breaking down starch into simple sugars which can then be absorbed in the small intestine. Blocking this digestive enzyme prevents the digestion of complex carbohydrates and they pass undigested through the Gastrointestinal tract. The end result is a decrease in the number of calories absorbed, potentially promoting weight loss.

Methods: Fifty obese adults (body mass index 30-43 kg/m) were screened to participate in a randomized, double blind, placebo-controlled study evaluating the effects of treatment with the Phaseolamin (white kidney bean extract) Starch Neutralizer�-brand bean extract (Pharmachem Laboratories, Inc.) vs. placebo on weight loss. It was hypothesized that ingestion of the Phaseolamin (white kidney bean extract) product (a non-stimulant alpha amylase inhibitor) concurrent with meals would reduce the total amount of calories absorbed and would result in weight loss. In addition, by reducing the amount of simple sugars absorbed and delivered to the liver, this process would reduce the amount of Triglycerides produced by the liver.

Participants were randomized to receive either 1500mg of Phaseolamin (white kidney bean extract) or an identical placebo twice a day with meals. Subjects were asked to maintain a high fiber, low fat, controlled diet that included 100 to 200g of carbohydrates per day. Subjects were asked not to change their current exercise regimen during the study. The active study period was 8 weeks. Thirty-nine subjects completed the initial screening process and twenty-seven subjects completed the study.

Results: The study results at 8 weeks demonstrated that the active (Phaseolamin) group lost an average of 3.79 pounds total (average of 0.47 pounds per week) compared with the placebo group which lost an average of 1.65 pounds total (average of 0.21 pounds per week). The difference is 129% with a p-value of 0.35. Subjects in the Phaseolamin (white kidney bean extract) group decreased their waist size by an average of 1.46 inches at 8 weeks, which was 36% greater than the placebo group which lost an average of 1.07 inches off their waist (p=0.43). Energy level, as measured by a 10-point Likert scale, increased by 13%, from 4.8 to 6.2, in the Phaseolamin (white kidney bean extract) group, and did not change at all in the placebo group (p=0.20). Triglyceride levels in the Phaseolamin (white kidney bean extract) group were reduced by an average of 26.3 mg/dl, which was 224% more than the 8.1mg/dl drop seen in the placebo group (p=0.07). Several secondary test parameters, including hip size, body fat, appetite control, hunger, HbA1C and total cholesterol were also measured. None of these secondary outcomes demonstrated statistically significant differences between groups.

Safety: There were no reported adverse events during the study. Only one subject in each group dropped out due to side effects. The placebo subject who dropped out complained of pain, bloating, and gas. The Phaseolamin (white kidney bean extract) subject who dropped out complained of an increase in the frequency of her tension headaches. Safety data including electrolytes, and kidney and liver function tests showed no clinically or statistically significant changes in either group.

Conclusion: Clinical trends were identified for weight loss, inches lost from the waist, energy, and decrease in Triglycerides, although statistical significance was not reached. The reason that significance was not achieved was the small number of subjects who completed the study and the wide variability of the results within each group. Further studies with larger numbers of subjects are necessary in order to definitively demonstrate effectiveness. In conclusion, the Phaseolamin (white kidney bean extract) product demonstrates clinical differences in several clinically relevant variables and shows promise as an adjunctive therapy in the treatment of Obesity and Hypertriglyceridemia.

[dr.j]

Carini come studi....

[menphisdaemon]

Difatti la voglio approfondire come cosa...

Sul tuo post di prima...fosse per me sarei sempre lì...mi sento bene in vostra compagnia e la passione...eh la passione. Però son 300 Km e se il lunedì si lavora

Per ciò che riguarda l'allenamento sto a cavallo, sugli esercizi devo invece fare un discorso parzialmente diverso...quello che ti dicevo ieri...Farah... "stick to the exercises that work for you"...ed ovviamente intente la base, per poi variare lo stimolo nei complementari. Sull'alimentazione sono una macchina..già lo sai..ma devo spingere di + nei cheat mi sa

[dr.j]

Lo so lo so Marco

Quanto all'allenamento.....invece credo che anche lì ci siano diverse cose da correggere.....varianti, adattamenti alla struttura....ed esecuzioni......queste cose stanno alla base della mia pianificazione degli allenamenti......ecco dove nascono le fondamenta per poi costruirci una bella routine produttiva......e mentre ti scaldavi ho già visto qualche pecca.....ma ne parleremo sul campo..........ora finisco di fare il rompichez Marco e vado sul divano con un po' di scartoffie.......

[dr.j]

da settembre doc verro' a trovarti spesso la domenica per dei w.o. assieme...

Ti conviene!
Ti aspetto bro....

[twins]

Altra cosa da tenere in mente Marco, relativa ai discorsi fatti è che devi veramente individuare un buon sistema di allenamento, ben ciclizzato, con esercizi target e supportarti con un'alimentazione veramente "solida" nel senso lato della cosa sono ripetitivo? un po' è che son abituato a certi "canoni" e l'altra parte.....sono un arteriosclerotico! Detto questo.....Fede mi ha appena detto che secondo lui dovresti passare più tempo in sua/nostra compagnia!

non sai quanto tempo ci passerei io con voi. gruppo fantastico ieri! tra l altro in 2 secondi mi hai fatto capire un paio di cose su come usare la hummer per il petto.
in compenso stasera mi hai ucciso...anche martello pneumatico walter è arrivato QUASI al limite
tutta salute!!

[Pippo mio]

Come ti accennavo ieri...dallo spunto di pippo mio ho approfondito...diciamo che pippo ed io facciamo danni quando ci fissiamo su certe cosette.. vero Vale??

belli...senza dubbio è intrigante

[dr.j]

non sai quanto tempo ci passerei io con voi. gruppo fantastico ieri! tra l altro in 2 secondi mi hai fatto capire un paio di cose su come usare la hummer per il petto.
in compenso stasera mi hai ucciso...anche martello pneumatico walter è arrivato QUASI al limite
tutta salute!!

mooooooooooooolto bene Andrea!

E ce ne sarebbero un'infinità di variabiliti e trucchetti per ogni esercizio......anche ieri Fede ne ha provato un altro molto importante per il petto.....tutti da provare sul campo

[GS1]

gambe in palestra dal mmio amico max, tanto rustica qunato efficace...non riesco a star seduto